MedTrace Logo

Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly

NCT04414319 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2023-07-20

No results posted yet for this study

Summary

In most diseases, older people have less typical symptomatology than that described for younger people. The investigators therefore hypothesize that within the framework of coronavirus disease 19, the clinical pictures in the elderly will present specificities that will need to be described. Moreover, since infection by the severe acute respiratory syndrome (SARS-CoV-2) virus is new to humans, the investigators do not yet have sufficient information on the fate of the elderly, in terms of loss of autonomy, rehospitalization, institutionalization, mortality, etc. the investigators therefore assume that the clinical pictures in the elderly will present specificities that will need to be described. The investigators hypothesize that an acute infection of this type will have short-, medium-, and long-term repercussions in the elderly.

Conditions

  • SARS-CoV 2

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Moustapha DRAME, PHD · Unversity hospital of Martinique

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2021-04-15
Completion
2023-04-13

Countries

  • France
  • Guadeloupe
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04414319 on ClinicalTrials.gov